Wednesday, January 27, 2010

Acnamino




Acnamino may be available in the countries listed below.


Ingredient matches for Acnamino



Minocycline

Minocycline hydrochloride (a derivative of Minocycline) is reported as an ingredient of Acnamino in the following countries:


  • United Kingdom

International Drug Name Search

Picolax




Picolax may be available in the countries listed below.


Ingredient matches for Picolax



Sodium Picosulfate

Sodium Picosulfate is reported as an ingredient of Picolax in the following countries:


  • Bahrain

  • Iraq

  • Ireland

  • Jordan

  • Kuwait

  • Lebanon

  • Libya

  • Oman

  • Portugal

  • Qatar

  • Saudi Arabia

  • Sudan

  • United Arab Emirates

  • Yemen

International Drug Name Search

Sunday, January 24, 2010

Supeslone




Supeslone may be available in the countries listed below.


Ingredient matches for Supeslone



Trimebutine

Trimebutine maleate (a derivative of Trimebutine) is reported as an ingredient of Supeslone in the following countries:


  • Japan

International Drug Name Search

Sunday, January 10, 2010

Degarelix




In the US, Degarelix (degarelix systemic) is a member of the following drug classes: gonadotropin-releasing hormone antagonists, hormones/antineoplastics and is used to treat Prostate Cancer.

US matches:

  • Degarelix

  • Degarelix Acetate

  • Degarelix Subcutaneous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L02BX02

CAS registry number (Chemical Abstracts Service)

0214766-78-6

Chemical Formula

C82-H103-Cl-N18-O16

Molecular Weight

1632

Therapeutic Categories

Antineoplastic agent

Gonadotropin releasing hormone (GnRH) receptor antagonist

Chemical Names

D-Alaninamide, N-acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-4-[[[(4S)-hexahydro-2,6-dioxo-4-pyrimidinyl]carbonyl]amino]-L-phenylalanyl-4-[(aminocarbonyl)amino]-D-phenylalanyl-L-leucyl-N⁶-(1-methylethyl)-L-l (USAN)

N-acetyl-3-(naphtalen-2-yl)-D-alanyl-4-chloro-D-phenylalanyl-3-(pyridin-3-yl)-D-alanyl-L-seryl-4-[[[(4S)-2,6-dioxohexahydroprymidin-4-yl]carbonyl]amino]-L-phenylalanyl-4-(carbamoylamino)-D-phenylalanyl-L-leucyl-N⁶-(1-methylethyl)-L-lysyl-L-prolyl-D-alanin (WHO)

Foreign Names

  • Degarelixum (Latin)
  • Degarelix (German)
  • Dégarélix (French)
  • Degarelix (Spanish)

Generic Names

  • Degarelix (OS: USAN)
  • Degarelix Acetate (OS: USAN)
  • ASP-3550 (IS)
  • FE200486 (IS)

Brand Names

  • Firmagon
    Ferring, Greece


  • Degarelix for Injection
    Ferring, United States


  • Firmagon
    Ferring, Austria; Ferring, Switzerland; Ferring, Germany; Ferring, France; Ferring, United Kingdom; Ferring, United States


  • FIRMAGON
    Ferring, Sweden

International Drug Name Search

Glossary

ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday, January 8, 2010

Brivudine




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AB15

CAS registry number (Chemical Abstracts Service)

0069304-47-8

Chemical Formula

C11-H13-Br-N2-O5

Molecular Weight

333

Therapeutic Category

Antiviral agent

Chemical Name

(E)-5-(2-bromovinyl)-2'-deoxyuridine

Foreign Names

  • Brivudinum (Latin)
  • Brivudin (German)
  • Brivudine (French)
  • Brivudina (Spanish)

Brand Names

  • Bridic
    Menarini, Portugal


  • Brival
    Berlin-Chemie, Romania


  • Brivex
    Menarini, Switzerland


  • Brivir
    Berlin-Chemie, Bulgaria; Menarini, Greece


  • Brivirac
    Menarini, Italy


  • Brivox
    Menarini, Costa Rica; Menarini, Dominican Republic; Menarini, Guatemala; Menarini, Honduras; Menarini, Nicaragua; Menarini, Panama; Menarini, El Salvador


  • Brivumen
    Berlin-Chemie, Estonia; Berlin-Chemie, Lithuania; Berlin-Chemie, Latvia


  • Brivuzost
    Berlin-Chemie, Croatia (Hrvatska); Berlin-Chemie, Serbia


  • Menavir
    Berlin-Chemie, Germany


  • Mevir
    Guidotti, Austria


  • Nervinex
    Menarini, Spain


  • Premovir
    Berlin-Chemie, Germany; Berlin-Chemie, Poland; Sanolabor, Slovenia


  • Virocid
    Berlin Chemie, Bosnia & Herzegowina


  • Zecovir
    Guidotti, Italy


  • Zerpex
    Guidotti, Luxembourg; Menarini, Belgium; Menarini, Luxembourg


  • Zonavir
    Guidotti, Luxembourg; Menarini, Luxembourg


  • Zostevir
    Berlin-Chemie, Czech Republic


  • Zostex
    Berlin-Chemie, Germany; I.E. Ulagay, Turkey; Laboratori Guidotti, Austria


  • Zostydol
    Menarini, Argentina


  • Zovudex
    Berlin-Chemie, Slovakia

International Drug Name Search

Glossary

Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, January 6, 2010

Depo-Provera




In some countries, this medicine may only be approved for veterinary use.


In the US, Depo-Provera (medroxyprogesterone systemic) is a member of the following drug classes: contraceptives, hormones/antineoplastics, progestins and is used to treat Abnormal Uterine Bleeding, Amenorrhea, Birth Control, Endometrial Cancer, Endometrial Hyperplasia - Prophylaxis, Endometriosis and Renal Cell Carcinoma.

US matches:

  • Depo-Provera

  • Depo-Provera Injectable Suspension

  • Depo-Provera Contraceptive injectable

  • Depo-Provera injectable

  • Depo-Provera Contraceptive

UK matches:

  • Depo-Provera 150 mg/ml Injection
  • Depo-Provera 150mg/ml Injection (SPC)

Ingredient matches for Depo-Provera



Medroxyprogesterone

Medroxyprogesterone 17α-acetate (a derivative of Medroxyprogesterone) is reported as an ingredient of Depo-Provera in the following countries:


  • Australia

  • Bahrain

  • Bangladesh

  • Belgium

  • Brazil

  • Canada

  • Colombia

  • Czech Republic

  • Denmark

  • Ecuador

  • Estonia

  • Ethiopia

  • Finland

  • Georgia

  • Greece

  • Hong Kong

  • Hungary

  • Iceland

  • India

  • Ireland

  • Israel

  • Italy

  • Latvia

  • Lithuania

  • Luxembourg

  • Malaysia

  • Netherlands

  • New Zealand

  • Norway

  • Oman

  • Peru

  • Philippines

  • Poland

  • Portugal

  • Romania

  • Singapore

  • South Africa

  • Sweden

  • Switzerland

  • Turkey

  • United Kingdom

  • United States

  • Venezuela

  • Vietnam

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday, January 3, 2010

Minero




Minero may be available in the countries listed below.


Ingredient matches for Minero



Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Minero in the following countries:


  • Denmark

Gestodene

Gestodene is reported as an ingredient of Minero in the following countries:


  • Denmark

International Drug Name Search